379 related articles for article (PubMed ID: 25990863)
1. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.
Somasundaram R; Prasad MA; Ungerbäck J; Sigvardsson M
Blood; 2015 Jul; 126(2):144-52. PubMed ID: 25990863
[TBL] [Abstract][Full Text] [Related]
2. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
3. Transcriptional circuits in B cell transformation.
Hu Y; Yoshida T; Georgopoulos K
Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
[TBL] [Abstract][Full Text] [Related]
4. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
[TBL] [Abstract][Full Text] [Related]
5. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
[TBL] [Abstract][Full Text] [Related]
6. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
7. B-cell identity as a metabolic barrier against malignant transformation.
Chan LN; Müschen M
Exp Hematol; 2017 Sep; 53():1-6. PubMed ID: 28655536
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.
Sigvardsson M
Genes Dev; 2023 Aug; 37(15-16):703-723. PubMed ID: 37673459
[TBL] [Abstract][Full Text] [Related]
9. Genes and childhood leukemia.
Kęsy J; Januszkiewicz-Lewandowska D
Postepy Hig Med Dosw (Online); 2015 Mar; 69():302-8. PubMed ID: 25748621
[TBL] [Abstract][Full Text] [Related]
10. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.
Zandi S; Mansson R; Tsapogas P; Zetterblad J; Bryder D; Sigvardsson M
J Immunol; 2008 Sep; 181(5):3364-72. PubMed ID: 18714008
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression of regulatory and differentiation-related genes in the key steps of human hematopoiesis: The LeukoStage Database.
Polgárová K; Vášková M; Froňková E; Slámová L; Kalina T; Mejstříková E; Dobiášová A; Fišer K; Hrušák O
Differentiation; 2016; 91(1-3):19-28. PubMed ID: 26674556
[TBL] [Abstract][Full Text] [Related]
12. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
13. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
Xu Z; Gwin KA; Li Y; Medina KL
BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
[TBL] [Abstract][Full Text] [Related]
14. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
15. New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
Kohlmann A; Schoch C; Dugas M; Schnittger S; Hiddemann W; Kern W; Haferlach T
Leukemia; 2005 Jun; 19(6):953-64. PubMed ID: 15815718
[TBL] [Abstract][Full Text] [Related]
16. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid progenitor cells from childhood acute lymphoblastic leukemia are functionally deficient and express high levels of the transcriptional repressor Gfi-1.
Purizaca J; Contreras-Quiroz A; Dorantes-Acosta E; Vadillo E; Arriaga-Pizano L; Fuentes-Figueroa S; Villagomez-Barragán H; Flores-Guzmán P; Alvarado-Moreno A; Mayani H; Meza I; Hernandez R; Huerta-Yepez S; Pelayo R
Clin Dev Immunol; 2013; 2013():349067. PubMed ID: 24198842
[TBL] [Abstract][Full Text] [Related]
19. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
20. Mechanisms of transcription factor deregulation in lymphoid cell transformation.
O'Neil J; Look AT
Oncogene; 2007 Oct; 26(47):6838-49. PubMed ID: 17934490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
